跳至主要内容
临床试验/IRCT2015080720715N2
IRCT2015080720715N2已完成2 期

Effect of Amlodipine on reduce of iron overload in patients with major thalassemia above 7 years old

Vice Chancellor for research of Arak University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
7 years 至 54 years(—)
性别
All

入选标准

  • Patients with major thalassemia ?? ?with ?regular blood transfusions; using iron chelating agents ?regularly; age above 7 years old.?
  • Exclusion criteria: Patients who changed their chelating ?agents during the last 6 months; renal and hepatic ?failure; cardiac output less than 35%; systolic blood ?pressure less than 90 millimeter Hg, patients with HIV ?and hepatitis B and C.?

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Arak University of Medical Sciences

相似试验